Reply Letter - Polypharmacy is a determinant of hospitalization in Parkinson's disease
Eur Rev Med Pharmacol Sci
.
2021 Dec;25(23):7193-7194.
doi: 10.26355/eurrev_202112_27410.
Authors
S Giovannini
1
,
A Laudisio
,
L Navarini
,
C Loreti
,
L Biscotti
,
L Padua
,
R Bernabei
,
G Zuccalà
Affiliation
1
Department of Geriatrics and Orthopaedics, Università Cattolica del Sacro Cuore, Rome, Italy. silvia.giovannini@unicatt.it.
PMID:
34919216
DOI:
10.26355/eurrev_202112_27410
No abstract available
Publication types
Letter
Comment
MeSH terms
Hospitalization
Humans
Parkinson Disease* / drug therapy
Polypharmacy*